InvestorsHub Logo
Replies to #324 on Amgen Inc (AMGN)
icon url

TheFinalCD

12/17/13 9:21 AM

#325 RE: ECole #324

Amgen Announces Positive Top-Line Results From Phase 3 MENDEL-2 Trial Of Evolocumab (AMG 145) In Patients With High Cholesterol